In an adult hypertensive patient on finerenone (nonsteroidal mineralocorticoid receptor antagonist) who recently started semaglutide (Ozempic) for weight loss and now has hypotension (blood pressure 75/61 mm Hg), should finerenone be discontinued?
The triple-agonist mechanism is promising, but promise is not approval
Willow does not prescribe FDA-approved brand-name medications
You should also go over all medications you currently take, such as glucose-lowering diabetes medications, blood pressure or thyroid meds, or anticoagulants
How Natural GLP1 Works in the Body Once released, natural GLP1 binds to specific receptors known as GLP-1 receptors
Such monitoring may include assessment of dietary protein intake, body composition trajectories, and micronutrient status in order to maintain proportionality between oxidative metabolic demand and substrate-supported regenerative capacity This perspective aligns with emerging calls to integrate pharmacologic and nutritional paradigms in obesity treatment, recognizing that durable metabolic adaptation requires coordination between drug-mediated signaling effects and substrate-dependent metabolic processes [103, 115]